![Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon study - ScienceDirect Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1551714410001928-gr1.jpg)
Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies — The Pre-Optimon study - ScienceDirect
![Guidelines for Developing a Data and Safety Monitoring Plan | National Institute on Drug Abuse (NIDA) Guidelines for Developing a Data and Safety Monitoring Plan | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/imagecache/content_image_landscape/images/colorbox/dsmbfig2.gif)
Guidelines for Developing a Data and Safety Monitoring Plan | National Institute on Drug Abuse (NIDA)
![Reasons for frequency of on-site monitoring visits. CTU could choose... | Download Scientific Diagram Reasons for frequency of on-site monitoring visits. CTU could choose... | Download Scientific Diagram](https://www.researchgate.net/publication/338497980/figure/fig1/AS:845613616869376@1578621405401/Reasons-for-frequency-of-on-site-monitoring-visits-CTU-could-choose-multiple-options.png)
Reasons for frequency of on-site monitoring visits. CTU could choose... | Download Scientific Diagram
![Figure 3 from Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study. | Semantic Scholar Figure 3 from Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/015efa2f4e87d314d203f2cb8c499320e85c89a5/7-Figure3-1.png)
Figure 3 from Validation of a risk-assessment scale and a risk-adapted monitoring plan for academic clinical research studies--the Pre-Optimon study. | Semantic Scholar
PLOS ONE: Pilot, double-blind, randomized, placebo-controlled clinical trial of the supplement food Nyaditum resae® in adults with or without latent TB infection: Safety and immunogenicity
![Guidelines for Developing a Data and Safety Monitoring Plan | National Institute on Drug Abuse (NIDA) Guidelines for Developing a Data and Safety Monitoring Plan | National Institute on Drug Abuse (NIDA)](https://nida.nih.gov/sites/default/files/images/colorbox/dsmbfig1.gif)
Guidelines for Developing a Data and Safety Monitoring Plan | National Institute on Drug Abuse (NIDA)
![Decision Tree for Data and Safety Monitoring Plan | NIH: National Institute of Allergy and Infectious Diseases Decision Tree for Data and Safety Monitoring Plan | NIH: National Institute of Allergy and Infectious Diseases](https://www.niaid.nih.gov/sites/default/files/treedatasafety.gif)